The Fiocruz response to the COVID-19

Research evaluates the effectiveness of four vaccines in cases of reinfection by COVID-19

The highest effectiveness was observed with the four vaccines in use in Brazil (Coronavac, AstraZeneca, Janssen, and Pfizer-BioNTech) in the prevention of COVID-19

COVID-19: Fiocruz and MSD sign an agreement to produce the first oral antiviral drug in Brazil

The Fiocruz Institute of Drug Technology (Farmanguinhos/Fiocruz) signed an agreement of technological cooperation with the American pharmaceutical company MSD (Merck Sharp & Dohme)

Fiocruz/NIH Symposium: COVID-19 demands new ways to distribute vaccines

“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford

Fiocruz receives the WHO's technical lead on COVID-19 and delegations of PAHO and Ministry of Health

Delegations debated lessons learned and challenges to maintain investments that were focused on the pandemic's preparedness for possible new public health emergencies.

Political use of misinformation impacts Covid-19 vaccination of children in Brazil

Download COVID-19 School Safety Portuguese Communications Kit

The TGHN Lusophone working group has produced free downloadable communications kit, in Portuguese, to help school managers, families and students to prevent COVID-19 transmission.